Predictive Severity Factors of COVID-19 in Patients with Rheumatic Immune Mediated Diseases

被引：0
|
作者：
Martinez-Lopez, David [1 ]
Ferraz Amaro, Ivan [2 ]
Prieto-Pena, Diana [3 ,4 ]
Benavides Villanueva, Fabricio [1 ]
Corrales, Cristina [1 ]
Sanchez-Bilbao, Lara [1 ]
Herrero-Morant, Alba [5 ]
Alvarez Reguera, Carmen [1 ]
Trigueros-Vazquez, Martin [1 ]
Wallmann, Reinhard [6 ]
Angel Gonzalez-Gay, Miguel [3 ,7 ,8 ,9 ]
Blanco, Ricardo [10 ]
机构：
[1] Hosp Univ Marques Valdecilla, Santander, Spain
[2] Hosp Univ Canarias, Div Rheumatol, Tenerife, Spain
[3] IDIVAL, Res Grp Genet Epidemiol & Atherosclerosis Syst Di, Santander, Spain
[4] Hosp Univ Marques Valdecilla, Dept Rheumatol, Santander, Spain
[5] Hosp Univ Marques Valdecilla, Ontinyent, Spain
[6] Serv Cantabro Salud, Santander, Spain
[7] Univ Cantabria, Dept Med & Psychiat, Santander, Spain
[8] Hosp Univ Marques Valdecilla, Rheumatol Div, Santander, Spain
[9] Univ Witwatersrand, Fac Hlth Sci, Cardiovasc Pathophysiol & Genom Res Unit, Sch Physiol, Johannesburg, South Africa
[10] Hosp Univ Marques Valdecilla, IDIVAL, Santander, Spain
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0817
引用
收藏
页码：1622 / 1624
页数：3
相关论文
共 50 条
  • [31] Correspondence on 'Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients'
    Kermani, Tanaz A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (10)
  • [32] FREQUENCY AND SEVERITY OF COVID-19 IN PATIENTS WITH VARIOUS RHEUMATIC DISEASES TREATED REGULARLY WITH COLCHICINE OR HYDROXYCHLOROQUINE
    Oztas, M.
    Bektas, M.
    Karacan, I.
    Aliyeva, N.
    Dag, A.
    Aghamuradov, S.
    Cevirgen, S. B.
    Sari, S.
    Bolayirli, M.
    Can, G.
    Hatemi, G.
    Seyahi, E.
    Ozdogan, H.
    Gul, A.
    Ugurlu, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1660 - 1661
  • [33] A predictive model for the severity of COVID-19 in elderly patients
    Zeng, Furong
    Deng, Guangtong
    Cui, Yanhui
    Zhang, Yan
    Dai, Minhui
    Chen, Lingli
    Han, Duoduo
    Li, Wen
    Guo, Kehua
    Chen, Xiang
    Shen, Minxue
    Pan, Pinhua
    AGING-US, 2020, 12 (21): : 20982 - 20996
  • [34] COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases
    Gauckler, Philipp
    Kesenheimer, Jana S.
    Geetha, Duvuru
    Odler, Balazs
    Eller, Kathrin
    Laboux, Timothee
    Alberici, Federico
    Zappa, Mattia
    Chebotareva, Natasha
    Moiseev, Sergey
    Bonilla, Marco
    Jhaveri, Kenar D.
    Oniszczuk, Julie
    Audard, Vincent
    Costa, Denise
    Mastroianni-Kirsztajn, Gianna
    Bruchfeld, Annette
    Muto, Masahiro
    Windpessl, Martin
    Mayer, Gert
    Kronbichler, Andreas
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [35] SEVERITY OF COVID-19 INFECTION IN RHEUMATIC IMMUNE-MEDIATEDINFLAMMATORY DISEASES. STUDY IN A SINGLE UNIVERSITY HOSPITAL
    Martinez-Lopez, D.
    Prieto-Pena, D.
    Sanchez-Bilbao, L.
    Herrero-Morant, A.
    Alvarez-Reguera, C.
    Trigueros-Vazquez, M.
    Gonzalez-Gay, M. A.
    Blanco, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1377 - 1377
  • [36] COVID-19 vaccines and rheumatic diseases
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2021, 3 (08): : E550 - E550
  • [37] COVID-19 vaccination in rheumatic diseases
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2021, 3 (10): : E688 - E688
  • [38] COVID-19 and inflammatory rheumatic diseases
    Hasseli, Rebecca
    Ladner, Ulf Muller
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (23) : 1564 - 1568
  • [39] COVID-19 and autoimmune rheumatic diseases
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (10): : E593 - E593
  • [40] Update on COVID-19 vaccines and autoimmune-mediated rheumatic diseases
    Suresh, Lakshmanan
    REUMATOLOGIA, 2021, 59 (04): : 203 - 205
12345